158 related articles for article (PubMed ID: 32922548)
1. Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy.
Kriegsmann M; Casadonte R; Maurer N; Stoehr C; Erlmeier F; Moch H; Junker K; Zgorzelski C; Weichert W; Schwamborn K; Deininger SO; Gaida M; Mechtersheimer G; Stenzinger A; Schirmacher P; Hartmann A; Kriegsmann J; Kriegsmann K
J Cancer; 2020; 11(20):6081-6089. PubMed ID: 32922548
[No Abstract] [Full Text] [Related]
2. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
Erlmeier F; Sun N; Shen J; Feuchtinger A; Buck A; Prade VM; Kunzke T; Schraml P; Moch H; Autenrieth M; Weichert W; Hartmann A; Walch A
Oncology; 2023; 101(2):126-133. PubMed ID: 36198279
[TBL] [Abstract][Full Text] [Related]
3. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
4. Histo-molecular differentiation of renal cancer subtypes by mass spectrometry imaging and rapid proteome profiling of formalin-fixed paraffin-embedded tumor tissue sections.
Möginger U; Marcussen N; Jensen ON
Oncotarget; 2020 Nov; 11(44):3998-4015. PubMed ID: 33216824
[TBL] [Abstract][Full Text] [Related]
5. Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.
Bin Satter K; Ramsey Z; Tran PMH; Hopkins D; Bearden G; Richardson KP; Terris MK; Savage NM; Kavuri SK; Purohit S
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805014
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
[TBL] [Abstract][Full Text] [Related]
8. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
9. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
10. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes.
Kriegsmann M; Zgorzelski C; Casadonte R; Schwamborn K; Muley T; Winter H; Eichhorn M; Eichhorn F; Warth A; Deininger SO; Christopoulos P; Thomas M; Longerich T; Stenzinger A; Weichert W; Müller-Tidow C; Kriegsmann J; Schirmacher P; Kriegsmann K
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967325
[TBL] [Abstract][Full Text] [Related]
12. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
13. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.
Liu J; Fanning CV
Cancer; 2001 Dec; 93(6):390-7. PubMed ID: 11748579
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
15. A genomic algorithm for the molecular classification of common renal cortical neoplasms: development and validation.
Gowrishankar B; Przybycin CG; Ma C; Nandula SV; Rini B; Campbell S; Klein E; Chaganti RS; Magi-Galluzzi C; Houldsworth J
J Urol; 2015 May; 193(5):1479-85. PubMed ID: 25498568
[TBL] [Abstract][Full Text] [Related]
16. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Random Forest, k-Nearest Neighbor, and Support Vector Machine Classifiers for Land Cover Classification Using Sentinel-2 Imagery.
Thanh Noi P; Kappas M
Sensors (Basel); 2017 Dec; 18(1):. PubMed ID: 29271909
[TBL] [Abstract][Full Text] [Related]
18. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma.
Zimpfer A; Janke S; Hühns M; Schneider B; Kundt G; Zettl H; Kilic E; Maruschke M; Hakenberg OW; Erbersdobler A
Pathol Res Pract; 2014 Aug; 210(8):521-5. PubMed ID: 24875296
[TBL] [Abstract][Full Text] [Related]
19. Chromophobe renal cell carcinoma: clinicopathological study of 7 cases.
Billis A; Carvalho RB; Magrini E; Mattos AC; Negretti F; Niero VR; Nogueira CR; Oliveira MC; Piovesan H; Ramos MJ; Rocha AG; Souza CA; Valença Júnior JT
Ultrastruct Pathol; 1998; 22(1):19-26. PubMed ID: 9491212
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation.
Carvalho LB; Jorge S; López-Fernández H; Lodeiro C; Dhir R; Campos Pinheiro L; Medeiros M; Santos HM; Capelo JL
Clin Proteomics; 2023 Nov; 20(1):54. PubMed ID: 38017382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
